Von Hippel–Lindau Protein (VHL) is a gatekeeper preventing renal cancer initiation [1–4], and mutations in VHL account for up to 70% of hereditary clear cell renal cell carcinoma (ccRCC) [5–7]. This evidence concerns the gene VHL and clear cell renal carcinoma.